Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Cat study provides insight into dementia progress
The latest findings also reinforce the benefit of cat owners recognising signs of disease.
The study found parallels in the development of cognitive disease in both cats and humans. 

The University of Edinburgh Royal (Dick) School of Veterinary Studies, alongside the University of California, has found that key proteins linked to cognitive disease are found in similar ways in both cats and humans.
 
This new research demonstrates that the development of feline cognitive dysfunction syndrome (CDS) functions similarly to dementia in several ways. 

It is hoped that these findings will support fast diagnosis and treatment of cognitive disease in cats and humans, as they assist in understanding the indicators of the disease. 

In the study, researchers aimed to understand how beta-amyloid and tau, two key proteins, develop in cats of all ages, and how they relate to the development of CDS. 

The research ultimately found that the accumulation of tau proteins, and the region in the brain in which this occurs, are key indicators of the progress of dementia in cats, and that the clinical signs developed in feline CDS are similar to that of human Alzheimers disease. 

Published in Frontiers in Aging, the study is available to read here. 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.